Mechanism of Mitf inhibition and morphological differentiation effects of hirsein A on B16 melanoma cells revealed by DNA microarray

Journal of Dermatological Science

Volumn 67, Issue 1, 2012, Pages 26-36

  Villareal, Myra O ^a   Han, Junkyu ^a   Ikuta, Kenjiro ^b   Isoda, Hiroko ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

B16 murine melanoma cells; Differentiation; Hirsein A; Mc1r; Mitf

Indexed keywords

ANTINEOPLASTIC AGENT; CELL RNA; F ACTIN; HIRSEIN A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DENDRITE; DNA MICROARRAY; DOWN REGULATION; DRUG MECHANISM; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GROWTH ARREST AND DNA DAMAGE INDUCIBLE 45 BETA GENE; HUMAN; HUMAN CELL; MELANOCORTIN 1 RECEPTOR GENE; MELANOCYTE; MELANOGENESIS; MELANOMA B16; MELANOMA CELL; MELANOMA DIFFERENTIATION ASSOCIATED GENE 7; MELANOSOME; MICROARRAY ANALYSIS; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; UPREGULATION; VALIDATION STUDY;

ACTINS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SHAPE; DITERPENES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERLEUKINS; MAP KINASE SIGNALING SYSTEM; MELANINS; MELANOMA, EXPERIMENTAL; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, MELANOCORTIN, TYPE 1; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84862166686     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.04.005     Document Type: Article

References (64)

1. Orlow S. Melanosomes are specialized members of the lysosomal lineage of organelles. J Invest Dermatol 1995, 105:3-7.
2. Potterf S.B., Muller J., Bernardini I., Tietze F., Kobayashi T., Hearing V.J., et al. Characterization of a melanosomal transport system in murine melanocytes mediating entry of the melanogenic substrate tyrosine. J Biol Chem 1996, 271:4002-4008.
3. Hearing V.J., Korner A.M., Pawelek J.M. New regulators of melanogenesis are associated with purified tyrosinase isozymes. J Invest Dermatol 1982, 79:16-18.
4. Kobayashi T., Urabe K., Winder A., Jimenez-Cervantes C., Imokawa G., Brewington T., et al. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994, 13:5818-5825.
5. Tsukamoto K., Jackson I.J., Urabe K., Montague P.M., Hearing V.J. A second tyrosinase-related protein TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 1992, 11:519-526.
6. Goding C.R. Mitf from neural crest to melanoma Signal transduction and transcription in the melanocyte lineage. Genes Dev 2000, 14:1712-1728.
7. Tachibana M. MITF: a stream flowing for pigment cells. Pigment Cell Res 2000, 13:230-240.
8. Gilchrest B.A., Eller M.S. DNA photodamage stimulates melanogenesis and other photoprotective responses. J Investig Dermatol Symp Proc 1999, 4:35-40.
9. Hearing V., Jimenez M. Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 1989, 2:75-85.
10. Levy C., Khaled M., Fisher D.E. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 2006, 12:406-414.
11. Widlund H.R., Fisher D.E. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene 2003, 22:3035-3041.
12. Bellei B., Maresca V., Flori E., Pitisci A., Larue L., Picardo M. p38 regulates pigmentation via proteasomal degradation of tyrosinase. J Biol Chem 2010, 285:7288-7299.
13. Englaro W., Rezzonico R., Durand-Clement M., Lallemand D., Ortonne J.P., Ballotti R. Mitogen-activated protein kinase pathway and AP-1 Are Activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem 1995, 270:24315-24320.
14. Bertolotto C., Abbe P., Hemesath T.J., Bille K., Fisher D.E., Ortonne J.P., et al. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 1998, 142:827-835.
15. Vetrini F., Auricchio A., Du J., Angeletti B., Fisher D.E., Ballabio A., et al. The microphthalmia transcription factor (Mitf) controls expression of the ocular albinism type 1 gene: link between melanin synthesis and melanosome biogenesis. Mol Cell Biol 2004, 24:6550-6559.
16. Chiaverini C., Beuret L., Flori E., Busca R., Abbe P., Bille K., et al. Microphthalmia-associated transcription factor regulates Rab27a gene expression and controls melanosome transport. J Biol Chem 2008, 283:12635-12642.
17. Bahadoran P., Aberdam E., Mantoux F. Rab27a: a key to melanosome transport in human melanocytes. J Cell Biol 2001, 152:843-849.
18. Wu X., Wang F., Rao K., Sellers J.R., Hammer J.A. Rab27a is an essential component of melanosome receptor for myosin Va. Mol Biol Cell 2002, 13:1735-1749.
19. Fukuda M., Kuroda T.S., Mikoshiba K. Slac2-a/Melanophilin, the missing link between Rab27 and Myosin Va, implications of a tripartite protein complex for melanosome transport. J Biol Chem 2002, 277:12432-12436.
20. Kuroda T.S., Ariga H., Fukuda M. The actin-binding domain of Slac2-a/Melanophilin is required for melanosome distribution in melanocytes. Mol Cell Biol 2003, 23:5245-5255.
21. Boissy R. Melanosome transfer to and translocation in the keratinocytes. Exp Dermatol 2003, 12:5-12.
22. Garraway L.A., Widlund H.R., Rubin M.A., Getz G., Berger A.J., Ramaswamy S., et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005, 436:117-122.
23. Sachs L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature 1978, 274:535-539.
24. Fisher P.B., Grant.S. Effects of interferon on differentiation of normal and tumor cells. Pharmacol Ther 1985, 27:143-166.
25. Leszczyniecka M., Roberts T., Dent P., Grant S., Fisher P.B. Differentiationtherapy of human cancer: basic science and clinical applications. Pharmacol Ther 2001, 90:105-156.
26. Jiang H., Lin J.J., Su Z.Z., Goldstein N.I., Fisher P.B. Subtraction hybridization identifies a novel melanoma differentiation associated gene Mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995, 11:2477-2486.
27. Fisher P.B., Gopalkrishnan R.V., Chada S., Ramesh R., Grimm E.A., Rosenfeld M.R., et al. Mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic. Cancer Biol Ther 2003, 2(4 Suppl. 1):S23-S37.
28. Chen H.D., Yang S.P., He X.F., Ai J., Liu Z.K., Liu H.B., et al. Trigochinins A-C: three new daphnane-type diterpenes from Trigonostemon chinensis. ChemInform 2010, 41.
29. He W., Cik M., Appendino G., Puyvelde L.V., Leysen J.E., De Kimpe N. Daphnane-type diterpene orthoesters and their biological activities. Mini Rev Med Chem 2002, 2:185-200.
30. Villareal M., Han J., Yamada P., Shigemori H., Isoda H. Hirseins inhibit melanogenesis by regulating the gene expressions of Mitf and melanogenesis enzymes. Exp Dermatol 2010, 19:617-627.
31. Miyamae Y., Orlina-Villareal M., Isoda H., Shigemori H. Hirseins A and B, daphnane diterpenoids from Thymelaea hirsuta that inhibit melanogenesis in B16 melanoma cells. J Nat Prod 2009, 72:938-941.
32. P)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition. FEBS Lett 1995, 375(3):231-234.
33. Maresca V., Flori E., Bellei B., Aspite N., Kovacs D., Picardo M. MC1R stimulation by α-MSH induces catalase and promotes its re-distribution to the cell periphery and dendrites. Pigment Cell Melanoma Res 2010, 23:263-275.
34. Saeed A.I., Bhagabati N.K., Braisted J.C., LiangW, Sharov V., Howe E.A., et al. TM4 microarray software suite. Methods Enzymol 2006, 411:134-193.
35. Vachtenheim J., Borovansky J. "Transcription physiology" of pigment formation in melanocytes: central role of MITF. Exp Dermatol 2009, 19:617-627.
36. Aoki H., Moro A. Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci 2002, 71:2171-2179.
37. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genomewide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868.
38. Tavazoie S., Hughes J.D., Campbell M.J., Cho R.J., Church G.M. Systematic determination of genetic network architecture. Nat Genet 1999, 22:281-285.
39. Kioka N., Sakata S., Kawauchi T., Amachi T., Akiyama S.K., Okazaki K., et al. Vinexin: a novel vinculin-binding protein with multiple SH3 domains enhances actin cytoskeletal organization. J Cell Biol 1999, 144:59-69.
40. Zhu S., Wurdak H., Wang Y., Galkin A., Tao H., Li J., et al. A genomic screen identifies TYRO3 as a MITF regulator in melanoma. Proc Natl Acad Sci U S A 2009, 106:17025-17030.
41. Corre S., Primot A., Sviderskaya E., Bennett D.C., Vaulont S., Goding C.R., et al. UV-induced expression of key component of the tanning process, the POMC and MC1R genes, is dependent on the p-38-activated upstream stimulating factor-1 (USF-1). J Biol Chem 2004, 279:51226-51233.
42. Adachi S., Morii E., Kim D., Ogihara H., Jippo T., Ito A., et al. Involvement of mi-transcription factor in expression of alpha melanocyte-stimulating hormone receptor in cultured mast cells of mice. J Immunol 2000, 164:855-860.
43. Mountjoy K.G., Robbins L.S., Nortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science 1992, 257:1248-1251.
44. De Smaele E., Zazzeroni F., Papa S., Nguyen D.U., Jin R., Jones J., et al. Induction of Gadd45b by NF-κB downregulates pro-apoptotic JNK signaling. Nature 2001, 414:308-313.
45. Kumar S., Boehm J., Lee J.C. p38 map kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003, 2:717-726.
46. Wysk M., Yang D.D., Lu H.T., Flavell R.A., Davis R.J. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc Natl Acad Sci U S A 1999, 96:3763-3768.
47. Lu H.T., Yang D.D., Wysk M., Gatti E., Mellman I., Davis R.J., et al. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J 1999, 18:1845-1857.
48. 2. J Biol Chem 1996, 271:26981-26988.
49. Sarkar S.A., Kutlu B., Velmurugan K., Kizaka-Kondoh S., Lee C.E., Wong R., et al. Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line. Diabetologia 2009, 52:1092-1101.
50. Chang L., Karin M. Mammalian MAP kinase signaling cascades. Nature 2001, 410:37-40.
51. Mansky K.C., Sankar U., Han J., Ostrowski M.C. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-κB ligand signaling. J Biol Chem 2002, 277:11077-11083.
52. Yen Y., ChuJ, Wang H., Xu H., Chou G., Leung A., et al. Involvement of p38 MAPK signaling pathway in the anti-melanogenic effect of San-bai-tang, a Chinese herbal formula, in B16 cells. J Ethnopharmacol 2010, 132:533-535.
53. Kawano M., Matsuyama K., Miyamae Y., Shinmoto H., Kchouk M.E., Morio T., et al. Antimelanogenesis effect of Tunisian herb Thymelaea hirsuta extract on B16 murine melanoma cells. Exp Dermatol 2007, 16:977-984.
54. Thody A.J. α-MSH and the regulation of melanocyte function. Ann N Y Acad Sci 1999, 885:217-229.
55. Scott G.A., Cassidy L. Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in murine melanoma model. J Invest Dermatol 1998, 111:243-250.
56. Canales R.D., Luo Y., Willey J.C., Austermiller B., Barbacioru C.C., Boysen C., et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol 2006, 24:1115-1122.
57. Jiang H., Su Z.Z., Lin J.J., Goldstein N.I., Young C.S., Fisher P.B. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci U S A 1996, 93:9160-9165.
58. Bennett D. Mechanism of differentiation in melanoma cells and melanocytes. Environ Health Perspect 1989, 80:49-59.
59. Edgar A.J., Bennett J.P. Inhibition of dendrite formation in mouse melanocytes transiently transfected with antisense DNA to myosinVa. J Anat 1999, 195:173-184.
60. Higa K., Shimmura S., Miyashita H., Shimazaki J., Tsubota K. Melanocytes in the corneal limbus interact with K19-positive basal epithelial cells. Exp Eye Res 2005, 81:218-223.
61. Ballestrem C., Wehrle-Haller B., Imhof B.A. Actin dynamics in living mammalian cells. J Cell Sci 1998, 111:1649-1658.
62. Scott G. Rac and Rho: the story behind melanocyte dendrite formation. Pigment Cell Res 2002, 15:322-330.
63. Abdel-Malek Z.A., Scott M.C., Furumura M., Lamoreux M.L., Ollmann M., Barsh G.S., et al. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J Cell Sci 2001, 114:1019-1024.
64. FurumuraM, Sakai C., Abdel-Malek Z.A., Barsh G.S., Hearing V.J. The interaction of agouti signal protein and melanocyte stimulating hormone to regulate melanin formation in mammals. Pigment Cell Res 1996, 9:191-203.